Difference between revisions of "Work Product for Review"

From QIBA Wiki
Jump to navigation Jump to search
 
(15 intermediate revisions by 4 users not shown)
Line 1: Line 1:
−
==Public Comment on QIBA Profiles and Protocols</font>==
+
[[Image:QIBA_WIKI_BLURB.jpg|600px]]
−
QIBA Profiles are posted for Public Comment to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details. 
 
  
−
The [[Committees|QIBA Biomarker Committees]] who develop QIBA Profiles and Protocols consider all comments submitted, and where appropriate, post responses.
+
<font color="red">NOTICE: These instructions are accessible on the QIBA Wiki as a historical reference only! Independent Profile Authoring Groups are required to oversee the various developmental stages from Draft to Public Comment to Consensus based on the current QUIC endorsement criteria, found HERE:</font> https://qibawiki.rsna.org/images/9/95/QUIC-Review-Criteria-for-New-Profiles-FINAL-v23SEPT2023.pdf.
  
−
==Directions for Comment Submission==
 
  
−
Use the [https://fs22.formsite.com/QIBA/QIBA_Public_Comment_Form/index.html public comment form] to submit comments concerning QIBA Profiles/Protocols to the QIBA Biomarker Committees.  Documents currently in the Public Comment phase are listed below. Submitted comments will be considered for the revised versions of these documents.
+
QIBA '''[[Profiles|Profile documents]]''' are posted for '''[[Public Comment Process|Public Comment]]''' to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details.
  
−
* If you have ''general comments'' about the Profile/Protocol concept, structure, process, etc., please e-mail those directly to ([mailto:sweinmann@rsna.org Susan Weinmann])
+
==Comment Submission==
  
 +
* ** provide a link to a public comment form (Google forms are recommended for ease of data capture) - ''see example'': [[Image:public comment form.jpg |1200px]]
 +
:* Select the document you are commenting on from the appropriate form
 +
:* Provide your name and email address
 +
:* Add the Profile section and line number (if applicable) to which your comment refers
 +
:* Describe the issue and your propose a resolution
 +
:* When you have entered each of your comments, you may submit the form
 +
* e-mail Profile Authoring Group with ''general comments'' about the Profile/Protocol concept, structure, process, etc.
  
−
'''<big><font color=red> Instructions: </font></big>'''
+
The [[Committees|QIBA Biomarker Committees]] consider all comments submitted, and where appropriate, post responses.
  
−
1. Visit the [https://fs22.formsite.com/QIBA/QIBA_Public_Comment_Form/index.html public comment form ]
+
==Public Comment Documents==
  
−
2. Select and download Profiles or Protocols for review (see link below).
+
see http://qibawiki.rsna.org/index.php/Profiles
−
 
 
−
*Profile:
 
−
*Protocol:
 
−
 
 
−
3. Designate '''Section''' or '''Line Number''' for each comment (or designate as "general"). 
 
−
 
 
−
4. Specify the '''Issue''' concisely and provide any new or replacement text in the '''Proposal''' section.
 
−
 
 
−
5. Designate the '''Priority''' of each comment as High ('''H'''), Medium ('''M'''), or Low ('''L''')
 
−
*  H:  Important issue where there is a major issue to be resolved; requires discussion and debate.
 
−
*  M:  Medium issue or clarification.  Requires discussion, but should not lead to long debate.
 
−
*  L: Typo or other minor classification that an editor can manage; requires no group discussion.
 
−
 
 
−
6. Comments are due by date listed next to each document.
 
−
 
 
−
==<font color=red> QIBA Profiles and Protocols for Reference </font>==
 
−
 
 
−
*[[Media:001.QIBA SPECT Profile.v0.1 2016.10.28.docx | QIBA Profile: <big><font color=red> QIBA Profile: Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016</font></big>]] ''The Public Comment period ends February 1, 2017.''
 
−
 
 
−
*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|QIBA SPECT Profile Conformance Checklist]]
 
−
 
 
−
 
 
−
*[[Media:QIBA_CT_Vol_LungNoduleAssessmentInCTScreening_v5-2-16b.docx|QIBA Profile: <big><font color=red> QIBA Profile: Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening, June 1, 2016</font></big>]] ''The Public Comment period has closed''
 
−
 
 
−
*[[Media:QIBA Small Nodule Profile References - Accuracy.xlsx|QIBA Spreadsheet: <big><font color=red> Small Nodule Profile References_Accuracy. Version for Public Comment. June 1, 2016 </font></big>]] ''The Public Comment period has closed''
 
−
 
 
−
*[[Media:QIBA Small Nodule Profile References - Precision.xlsx|QIBA Spreadsheet: <big><font color=red> Small Nodule Profile References_Precision. Version for Public Comment. June 1, 2016 </font></big>]] ''The Public Comment period has closed''
 
  
  
 
*[[Document Archive]]
 
*[[Document Archive]]

Latest revision as of 16:56, 19 January 2024

QIBA WIKI BLURB.jpg

NOTICE: These instructions are accessible on the QIBA Wiki as a historical reference only! Independent Profile Authoring Groups are required to oversee the various developmental stages from Draft to Public Comment to Consensus based on the current QUIC endorsement criteria, found HERE: https://qibawiki.rsna.org/images/9/95/QUIC-Review-Criteria-for-New-Profiles-FINAL-v23SEPT2023.pdf.


QIBA Profile documents are posted for Public Comment to ensure stakeholder representation, transparency and quality review. Interested people are encouraged to provide input on the document, the scenarios and use cases they address, the technologies proposed and other details.

Comment Submission

  • ** provide a link to a public comment form (Google forms are recommended for ease of data capture) - see example: Public comment form.jpg
  • Select the document you are commenting on from the appropriate form
  • Provide your name and email address
  • Add the Profile section and line number (if applicable) to which your comment refers
  • Describe the issue and your propose a resolution
  • When you have entered each of your comments, you may submit the form
  • e-mail Profile Authoring Group with general comments about the Profile/Protocol concept, structure, process, etc.

The QIBA Biomarker Committees consider all comments submitted, and where appropriate, post responses.

Public Comment Documents

see http://qibawiki.rsna.org/index.php/Profiles


Retrieved from "https://qibawiki.rsna.org/index.php?title=Work_Product_for_Review&oldid=19619"